alexa Kurtulus Gokduman | Harvard University
ISSN: 1948-5948

Journal of Microbial & Biochemical Technology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Kurtulus Gokduman

Kurtulus Gokduman Kurtulus Gokduman
Massachusetts General Hospital
Harvard Medical School
Harvard University

Dr. Kurtulus Gokduman received his B.Sc. degree in Biology, M.Sc. degree in Biotechnology, and Ph.D. degree in Biotechnology from Middle East Technical University, Ankara, Turkey. During his Ph.D. studies, he focused on the development of molecular genetic tools for Salmonella detection, as well as on the development of targeted and sustained delivery of Camptothecin anticancer drugs in bioactive form using iron oxide micro and nanoparticles. These researches have led to several publications and national/international patent applications. He performed post-doctoral research at Harvard Medical School, Harvard University, Boston, MA-USA, on the development of tumor on a chip test platform for bacterial cancer therapy, as well as on the investigation of hepatotoxicity profiles of super paramagnetic iron oxide nanoparticles using primary rat hepatocyte models. Currently his researches focus on cancer nanotechnology applications involving super paramagnetic iron oxide nanoparticles; bacterial cancer therapy; early diagnosis of cancer and other diseases using miRNA expression levels; treatment of cancer and other diseases using stem cells; and the development of tumor/organ on a chip models for medical diagnostics, targeted drug delivery, drug screening, and toxicological studies.

Research Interest

Cancer nanotechnology; bacterial cancer therapy; miRNAs;stem cell therapy; tumor/organ on a chip models

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version